• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic.在新冠疫情期间，类似新冠病毒感染的检查点抑制剂肺炎。
Lung Cancer. 2020 Aug;146:376-377. doi: 10.1016/j.lungcan.2020.06.013. Epub 2020 Jun 17.
2
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era.免疫检查点抑制剂在 COVID-19 时代的癌症治疗中的应用。
Clin Cancer Res. 2020 Aug 15;26(16):4201-4205. doi: 10.1158/1078-0432.CCR-20-1657. Epub 2020 Jun 15.
3
Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic?在新冠疫情期间，免疫疗法对口腔癌患者来说是首选方案吗？
Oral Oncol. 2020 Aug;107:104860. doi: 10.1016/j.oraloncology.2020.104860. Epub 2020 Jun 15.
4
Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?SARS-CoV-2感染的癌症患者中的免疫检查点抑制剂：点燃战火的火花？
Lung Cancer. 2020 Jul;145:208-210. doi: 10.1016/j.lungcan.2020.05.006. Epub 2020 May 11.
5
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.COVID-19 疫情对意大利癌症免疫治疗的影响：对年轻肿瘤学家的调查。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001154.
6
Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.曾接触过免疫检查点抑制剂的癌症患者感染2019冠状病毒病（COVID-19）的临床结局
Cancer Commun (Lond). 2020 Aug;40(8):374-379. doi: 10.1002/cac2.12077. Epub 2020 Jul 15.
7
Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.COVID-19 对癌症免疫治疗相关风湿并发症患者的影响：一项注册调查研究结果。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001550.
8
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment.免疫检查点抑制剂和 COVID-19 引起的肺炎：癌症治疗中的当前关注点。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000952.
9
Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.在 COVID-19 大流行期间的节拍口服长春瑞滨和肺癌治疗：单中心经验。
Lung Cancer. 2020 Jul;145:83-84. doi: 10.1016/j.lungcan.2020.05.001. Epub 2020 May 6.
10
SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context.肺癌患者的新型冠状病毒2型感染：当前临床背景
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):684. doi: 10.1016/j.arbres.2020.03.018. Epub 2020 Mar 31.

引用本文的文献

1
Interactions between interstitial lung abnormalities and immune checkpoint inhibitor therapy in non-small cell lung cancer: A review of current understanding and future directions.非小细胞肺癌中肺间质异常与免疫检查点抑制剂治疗的相互作用：当前认识与未来方向综述
Hum Vaccin Immunother. 2025 Dec;21(1):2504243. doi: 10.1080/21645515.2025.2504243. Epub 2025 May 14.
2
Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.SARS-CoV-2 通过上调 PD-L1 促进免疫逃逸。
J Med Virol. 2023 Feb;95(2):e28478. doi: 10.1002/jmv.28478.
3
Pembrolizumab-related pneumonitis in a patient with COVID-19 infection.一名新冠病毒感染患者发生的帕博利珠单抗相关性肺炎。
Singapore Med J. 2023 Jul;64(7):454-458. doi: 10.11622/smedj.2022083.
4
Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19.COVID-19 中的抑制性免疫检查点分子和 T 细胞耗竭。
Physiol Res. 2021 Dec 16;70(S2):S227-S247. doi: 10.33549/physiolres.934757.
5
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy.免疫失调相关感染：癌症免疫治疗的一种新出现的并发症。
Thorax. 2022 Mar;77(3):304-311. doi: 10.1136/thoraxjnl-2021-217260. Epub 2021 Oct 4.
6
Immune checkpoint inhibition in COVID-19: risks and benefits.免疫检查点抑制在 COVID-19 中的风险和益处。
Expert Opin Biol Ther. 2021 Sep;21(9):1173-1179. doi: 10.1080/14712598.2021.1887131. Epub 2021 Feb 17.
7
Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes.2019冠状病毒病对肺部的影响：聚焦潜在恶性表型
Cancers (Basel). 2020 Dec 18;12(12):3822. doi: 10.3390/cancers12123822.
8
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.接受免疫检查点抑制剂治疗的晚期癌症患者的有症状COVID-19：FICOG多中心观察性试验的前瞻性分析
Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.
9
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.SARS-CoV-2感染时代的癌症与免疫检查点抑制剂治疗
Cancers (Basel). 2020 Nov 16;12(11):3383. doi: 10.3390/cancers12113383.
10
Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review.瑞德西韦在 2019 冠状病毒病大流行中的应用：小型综述。
J Microbiol Immunol Infect. 2021 Feb;54(1):27-36. doi: 10.1016/j.jmii.2020.09.002. Epub 2020 Oct 5.

本文引用的文献

1
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
2
COVID-19 Autopsies, Oklahoma, USA.美国俄克拉荷马州的 COVID-19 尸检。
Am J Clin Pathol. 2020 May 5;153(6):725-733. doi: 10.1093/ajcp/aqaa062.
3
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review.新型冠状病毒病 2019（COVID-19）的胸部 CT 表现：影像学综述。
Eur Radiol. 2020 Aug;30(8):4381-4389. doi: 10.1007/s00330-020-06801-0. Epub 2020 Mar 19.
4
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.新型冠状病毒肺炎（COVID-19）的潜伏期来自公开报告的确诊病例：估计和应用。
Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.
5
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.两例肺癌患者 2019 年新型冠状病毒（COVID-19）肺炎早期阶段的肺部病理学表现。
J Thorac Oncol. 2020 May;15(5):700-704. doi: 10.1016/j.jtho.2020.02.010. Epub 2020 Feb 28.
6
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
7
Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis.免疫检查点抑制剂相关性肺炎的临床诊断与治疗。
Thorac Cancer. 2020 Jan;11(1):191-197. doi: 10.1111/1759-7714.13240. Epub 2019 Nov 24.
8
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancer.免疫检查点抑制剂治疗非小细胞肺癌重度级别的免疫检查点抑制剂性肺炎患者的高死亡率和低治疗效果。
Thorac Cancer. 2019 Oct;10(10):2006-2012. doi: 10.1111/1759-7714.13187. Epub 2019 Sep 3.
9
Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature.比较 PD-1 与 PD-L1 抑制剂在非小细胞肺癌中的毒性特征：文献系统分析。
Cancer. 2018 Jan 15;124(2):271-277. doi: 10.1002/cncr.31043. Epub 2017 Sep 28.
10
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.接受抗程序性死亡蛋白1/程序性死亡配体1治疗的患者发生的肺炎
J Clin Oncol. 2017 Mar;35(7):709-717. doi: 10.1200/JCO.2016.68.2005. Epub 2016 Sep 30.

Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic.

作者信息

Chang Hsu-Liang, Wei Po-Ju, Wu Kuan-Li, Huang Hung-Ling, Yang Chih-Jen

机构信息

Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Lung Cancer. 2020 Aug;146:376-377. doi: 10.1016/j.lungcan.2020.06.013. Epub 2020 Jun 17.

DOI:10.1016/j.lungcan.2020.06.013
PMID:32576385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834130/
Abstract
摘要